000516.SZ SHZ
Xi'an International Medical Investment Company Limited
1W: +1.2%
1M: +6.3%
3M: +10.3%
YTD: -11.9%
1Y: -18.6%
3Y: -50.1%
5Y: -78.1%
¥4.37 ($0.65)
+0.10 (+2.34%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$4.8B
+4.3% ▲
5Y CAGR: +37.2%
Gross Profit
$426M
+1.9% ▲
5Y CAGR: +26.0%
Operating Income
-$342M
+25.9% ▲
Net Income
-$254M
+31.0% ▲
EPS (Diluted)
$-0.11
+31.2% ▲
EBITDA
$511M
+14.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $1.6B | $2.9B | $2.7B | $4.6B | $4.8B |
| YoY Growth | +62.2% | +81.8% | -7.2% | +70.3% | +4.3% |
| Cost of Revenue | $1.8B | $2.9B | $2.9B | $4.2B | $4.4B |
| Gross Profit | -$157M | $30M | -$202M | $418M | $426M |
| Gross Margin | -9.8% | 1.0% | -7.4% | 9.1% | 8.9% |
| R&D Expenses | $10M | $13M | $16M | $10M | $7M |
| SG&A Expenses | $443M | $657M | $633M | $647M | $548M |
| Operating Expenses | -$165M | $936M | $931M | $880M | $768M |
| Operating Income | $8M | -$906M | -$1.1B | -$462M | -$342M |
| Operating Margin | 0.5% | -31.0% | -41.8% | -10.0% | -7.1% |
| Interest Expense | $157M | $198M | $196M | $219M | $181M |
| Income Before Tax | $7M | -$920M | -$1.1B | -$467M | -$345M |
| Tax Expense | -$27M | -$74M | $55M | $5M | $20M |
| Net Income | $45M | -$822M | -$1.2B | -$368M | -$254M |
| Net Margin | 2.8% | -28.1% | -43.4% | -8.0% | -5.3% |
| EPS (Diluted) | $0.02 | $-0.37 | $-0.52 | $-0.16 | $-0.11 |
| EBITDA | -$265M | -$105M | -$275M | $447M | $511M |
| Shares Outstanding | 1.93B | 2.22B | 2.25B | 2.30B | 2.31B |